Abstract:Background: Staphylococcus aureus is a widely distributed and highly pathogenic zoonotic bacterium. Sortase A represents a crucial target for the research and development of novel antibacterial drugs. Objective: This study aims to establish quantitative structure-activity relationship models based on the chemical structures of a class of benzofuranene cyanide derivatives. The models will be used to screen new antibacterial agents and predict the properties of these molecules. Method: The compounds were randomly divided into a training set and a test set. A large number of descriptors were calculated using the software, and then the appropriate descriptors were selected to build the models through the heuristic method and the gene expression programming algorithm. Results: In the heuristic method, the determination coefficient, determination coefficient of cross-validation, F-test, and mean squared error values were 0.530, 0.395, 9.006, and 0.047, respectively. In the gene expression programming algorithm, the determination coefficient and the mean squared error values in the training set were 0.937 and 0.008, respectively, while in the test set, they were 0.849 and 0.035. The results showed that the minimum bond order of a C atom and the relative number of benzene rings had a significant positive contribution to the activity of compounds. Conclusion: In this study, two quantitative structure-activity relationship models were successfully established to predict the inhibitory activity of a series of compounds targeting Staphylococcus aureus Sortase A, providing insights for further development of novel anti-Staphylococcus aureus drugs.

Structure-Guided Design, Synthesis, and Antivirulence Assessment of Covalent Staphylococcus aureus Sortase A Inhibitors

Synthesis, Biological Evaluation and Molecular Docking Analysis of 2-Phenyl-benzofuran-3-carboxamide Derivatives As Potential Inhibitors of Staphylococcus Aureus Sortase A

Discovery of Sortase A Covalent Inhibitors with Benzofuranene Cyanide Structures As Potential Antibacterial Agents Against Staphylococcus Aureus.

NMR Structure‐based Optimization of Staphylococcus Aureus Sortase A Pyridazinone Inhibitors

Antiinfective Therapy with a Small Molecule Inhibitor of Staphylococcus Aureus Sortase.

Novel Inhibitor Discovery of Staphylococcus Aureus Sortase B and the Mechanism Confirmation Via Molecular Modeling.

Synthesis, Biological Evaluation and Molecular Docking of 2-Phenyl-benzo[d]oxazole-7-carboxamide Derivatives As Potential Staphylococcus Aureus Sortase A Inhibitors

In-Silico Identified New Natural Sortase A Inhibitors Disrupt S. aureus Biofilm Formation

The Complete Assessment of Small Molecule and Peptidomimetic Inhibitors of Sortase A Towards Antivirulence Treatment

Discovery and structure–activity relationship analysis of Staphylococcus aureus sortase A inhibitors

Covalent sortase A inhibitor ML346 prevents Staphylococcus aureus infection of Galleria mellonella

Structure-Based Identification of a Potent Inhibitor Targeting Stp1-Mediated Virulence Regulation in Staphylococcus aureus

Quinone Skeleton As a New Class of Irreversible Inhibitors Against Staphylococcus Aureus Sortase A.

Synthesis, Antimicrobial Activities, and Molecular Modeling Studies of Agents for the Sortase A Enzyme

The Discovery of Novel Agents Against Staphylococcus Aureus by Targeting Sortase A: A Combination of Virtual Screening and Experimental Validation.

Oligopeptide Targeting Sortase A as Potential Anti-infective Therapy for Staphylococcus aureus .

QSAR Studies on a Class of Benzofuranene Cyanide Derivatives as Potential Inhibitors Targeting Staphylococcus aureus Sortase A

Biological and Biophysical Methods for Evaluation of Inhibitors of Sortase A in Staphylococcus aureus: An Overview

Isovitexin, a Potential Candidate Inhibitor of Sortase A of Staphylococcus aureus USA300

The Therapeutic Effect of Chlorogenic Acid Against Staphylococcus Aureus Infection Through Sortase A Inhibition